abrdn Healthcare Investors (HQH) Competitors $16.36 -0.01 (-0.03%) Closing price 08/28/2025 03:58 PM EasternExtended Trading$16.36 0.00 (-0.01%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HQH vs. PTY, ADX, RVT, GAB, NUV, STEW, OXLC, BCAT, CET, and GSBDShould you be buying abrdn Healthcare Investors stock or one of its competitors? The main competitors of abrdn Healthcare Investors include Pimco Corporate & Income Opportunity Fund (PTY), Adams Diversified Equity Fund (ADX), Royce Small-Cap Trust (RVT), Gabelli Equity Trust (GAB), Nuveen Municipal Value Fund (NUV), SRH Total Return Fund (STEW), Oxford Lane Capital (OXLC), BlackRock Capital Allocation Term Trust (BCAT), Central Securities (CET), and Goldman Sachs BDC (GSBD). These companies are all part of the "financial services" industry. abrdn Healthcare Investors vs. Its Competitors Pimco Corporate & Income Opportunity Fund Adams Diversified Equity Fund Royce Small-Cap Trust Gabelli Equity Trust Nuveen Municipal Value Fund SRH Total Return Fund Oxford Lane Capital BlackRock Capital Allocation Term Trust Central Securities Goldman Sachs BDC abrdn Healthcare Investors (NYSE:HQH) and Pimco Corporate & Income Opportunity Fund (NYSE:PTY) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk. Is HQH or PTY more profitable? Company Net Margins Return on Equity Return on Assets abrdn Healthcare InvestorsN/A N/A N/A Pimco Corporate & Income Opportunity Fund N/A N/A N/A Does the media prefer HQH or PTY? In the previous week, abrdn Healthcare Investors had 1 more articles in the media than Pimco Corporate & Income Opportunity Fund. MarketBeat recorded 1 mentions for abrdn Healthcare Investors and 0 mentions for Pimco Corporate & Income Opportunity Fund. abrdn Healthcare Investors' average media sentiment score of 1.64 beat Pimco Corporate & Income Opportunity Fund's score of 0.00 indicating that abrdn Healthcare Investors is being referred to more favorably in the media. Company Overall Sentiment abrdn Healthcare Investors Very Positive Pimco Corporate & Income Opportunity Fund Neutral Which has higher earnings & valuation, HQH or PTY? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioabrdn Healthcare InvestorsN/AN/AN/AN/AN/APimco Corporate & Income Opportunity FundN/AN/AN/AN/AN/A Which has more risk and volatility, HQH or PTY? abrdn Healthcare Investors has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Pimco Corporate & Income Opportunity Fund has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Do institutionals & insiders believe in HQH or PTY? 32.6% of abrdn Healthcare Investors shares are owned by institutional investors. Comparatively, 10.3% of Pimco Corporate & Income Opportunity Fund shares are owned by institutional investors. 7.3% of abrdn Healthcare Investors shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is HQH or PTY a better dividend stock? abrdn Healthcare Investors pays an annual dividend of $1.73 per share and has a dividend yield of 10.6%. Pimco Corporate & Income Opportunity Fund pays an annual dividend of $1.43 per share and has a dividend yield of 10.1%. Summaryabrdn Healthcare Investors beats Pimco Corporate & Income Opportunity Fund on 5 of the 6 factors compared between the two stocks. Get abrdn Healthcare Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for HQH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HQH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HQH vs. The Competition Export to ExcelMetricabrdn Healthcare InvestorsFIN IndustryFinance SectorNYSE ExchangeMarket Cap$881.72M$3.90B$12.52B$21.30BDividend Yield10.57%6.21%5.42%3.51%P/E RatioN/AN/A19.4429.34Price / SalesN/A24.1426.3250.85Price / CashN/A18.0322.1723.86Price / BookN/A1.122.365.39Net IncomeN/A$161.89M$1.01B$996.59M7 Day Performance-0.17%0.35%0.30%0.41%1 Month Performance2.63%2.14%2.51%3.49%1 Year Performance-14.68%1.24%540.25%12.09% abrdn Healthcare Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HQHabrdn Healthcare InvestorsN/A$16.370.0%N/A-13.8%$881.72MN/A0.00147,000Positive NewsPTYPimco Corporate & Income Opportunity FundN/A$14.09+0.1%N/A-0.8%$2.56BN/A0.00147,000ADXAdams Diversified Equity FundN/A$21.60-0.2%N/A+3.6%$2.55BN/A0.0030News CoveragePositive NewsRVTRoyce Small-Cap TrustN/A$15.98+0.4%N/A+4.7%$1.90BN/A0.0050News CoveragePositive NewsGABGabelli Equity TrustN/A$6.01+0.1%N/A+9.5%$1.84BN/A0.00N/ANews CoverageNUVNuveen Municipal Value FundN/A$8.64-0.3%N/A-1.7%$1.80BN/A0.00640News CoveragePositive NewsSTEWSRH Total Return FundN/A$18.20+0.0%N/A+18.2%$1.76BN/A0.00N/AOXLCOxford Lane Capital1.9676 of 5 stars$3.63+1.7%N/A-29.1%$1.65B$57.31M4.37601Positive NewsBCATBlackRock Capital Allocation Term TrustN/A$14.79-0.2%N/A-7.9%$1.59B$197.67M0.00147,000Positive NewsCETCentral SecuritiesN/A$49.93-0.1%N/A+13.0%$1.44B$222.17M0.006Positive NewsGSBDGoldman Sachs BDC1.3854 of 5 stars$11.29-1.2%$10.00-11.4%-18.6%$1.30B$161.13M8.96N/APositive News Related Companies and Tools Related Companies PTY Alternatives ADX Alternatives RVT Alternatives GAB Alternatives NUV Alternatives STEW Alternatives OXLC Alternatives BCAT Alternatives CET Alternatives GSBD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HQH) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding abrdn Healthcare Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share abrdn Healthcare Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access